INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 3 Apr · 15:31 IST

Ind-Swift Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹138.10
prior close
₹138.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-1.0+1.3-0.1+11.4+3.9+1.6+0.3+5.3+0.7+3.7+13.3+60.6
Up moveDown movePending
AI summary

Ind-Swift Laboratories Limited has submitted a compliance certificate under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018, for the quarter ended 31st March, 2026. The certificate was issued by Alankit Assignments Limited, the company's Registrar and Share Transfer Agent (RTA), on 1st April 2026. It confirms that physical share certificates received for dematerialization during the quarter have been listed on the stock exchanges, verified, mutilated, and cancelled, with the depository's name recorded as the registered owner. This is a standard quarterly procedural filing required by SEBI to ensure proper handling of physical-to-demat share conversions.

Likely market impact

This is a routine regulatory compliance filing with no material impact on the company's business, financials, or stock price. It simply confirms orderly processing of share dematerialization requests for the quarter.